The spatial and temporal dynamics of two intracellular second messengers, cAMP and Ca2 , were simultaneously monitored in living cells by digital fluorescence ratio imaging using FICRhR, a single-excitation dualemission cAMP indicator, and fura-2, a dual-excitation single- Given the physiological significance of the Ca2 /cAMP interplay, the potential ability to (i) simultaneously and continuously follow the single cell changes of cAMP and Ca2' and (ii) identify any putative subcellular compartmentalization of these important regulatory molecules would certainly help gain insights into the biochemical mechanisms underlying their dynamic interactions. As a first step toward this novel in vivo approach, we successfully monitored Ca2+ and cAMP kinetics in the same cells by dual-excitation dual-emission fluorescence ratio imaging using fura-2 and FICRhR. (3, 4) . These observations, together with the long-standing evidence that cAMP levels oscillate during the myocardial contraction cycle (5), have prompted the suggestion that, in heart, Ca2+/cAMP reciprocal effect (cAMP modulating Ca2+ homeostasis and Ca2+-inhibiting cAMP synthesis) could be the key mechanism for regulating cardiac rhythmicity and contractility (6). We have been specifically interested in the interplay between Ca2+ and cAMP in rat C6-2B glioma cells that, similar to heart cells, are highly responsive to catecholamines (7) and almost exclusively express type VI adenylyl cyclase (8) that is inhibited by Ca2+ in the low micromolar range (9). Thege biochemical features make C6-2B cells an ideal model for studying the Ca2+ regulation of hormone-stimulated cAMP accumulation (8-11) because virtually all cAMP produced, being synthesized by a Ca2+-inhibitable adenylyl cyclase, is under the potential control of Ca2+-mobilizing signals.
cAMP concentration ([cAMP] i) to be continuously monitored in space and time in living cells microinjected with the probe (12) (13) (14) (15) (16) (17) (18) (19) .
Given the physiological significance of the Ca2 /cAMP interplay, the potential ability to (i) simultaneously and continuously follow the single cell changes of cAMP and Ca2' and (ii) identify any putative subcellular compartmentalization of these important regulatory molecules would certainly help gain insights into the biochemical mechanisms underlying their dynamic interactions. As a first step toward this novel in vivo approach, we successfully monitored Ca2+ and cAMP kinetics in the same cells by dual-excitation dual-emission fluorescence ratio imaging using fura-2 and FICRhR. For this study, C6-2B cells and REF-52 fibroblasts were chosen as model systems by virtue of the differential Ca2+ regulation of the cAMP pathway, the latter cell line displaying Ca2+-insensitive cAMP accumulation.
Ca2l and cAMP are important second messengers that regulate a myriad of cell functions. In addition, there are numerous examples where regulatory interactions occur between them. Particularly interesting for their physiological relevance are the recent findings that (i) Ca2+ inhibits catecholamine-stimulated cAMP production and adenylyl cyclase activity in cardiac myocytes (1, 2) and (ii) a Ca2+-inhibited adenylyl cyclase (type V) is the predominant adenylyl cyclase isoform expressed in cardiac tissue (3, 4) . These observations, together with the long-standing evidence that cAMP levels oscillate during the myocardial contraction cycle (5) , have prompted the suggestion that, in heart, Ca2+/cAMP reciprocal effect (cAMP modulating Ca2+ homeostasis and Ca2+-inhibiting cAMP synthesis) could be the key mechanism for regulating cardiac rhythmicity and contractility (6) . We have been specifically interested in the interplay between Ca2+ and cAMP in rat C6-2B glioma cells that, similar to heart cells, are highly responsive to catecholamines (7) and almost exclusively express type VI adenylyl cyclase (8) that is inhibited by Ca2+ in the low micromolar range (9) . Thege biochemical features make C6-2B cells an ideal model for studying the Ca2+ regulation of hormone-stimulated cAMP accumulation (8) (9) (10) (11) because virtually all cAMP produced, being synthesized by a Ca2+-inhibitable adenylyl cyclase, is under the potential control of Ca2+-mobilizing signals.
While a number of imaging probes for Ca2+ exist, the recent introduction of FlCRhR, the first cAMP fluorescent probe (12) (14) . Cells were then loaded with 5 ,uM fura-2AM at room temperature for 30 min in Ham's F-10 medium supplemented with 20 mM Na/Hepes (pH 7.4), washed, and imaged in the same medium at 22°C. Drugs were diluted from stock solutions and added to the cells in serumfree Ham's F-10 medium containing 20 mM Na/Hepes (pH 7.4) and, in some experiments not shown, the phosphodiesterase inhibitors 3-isobutyl-1-methylxanthine (100 ,uM) and Ro20-1724 (100 ,uM) to prevent cAMP breakdown. 30-60 sec and fura-2 every 5-10 sec. In vitro calibration for fura-2 was performed as described (20) .
Materials. FICRhR (cAMP Fluorosensor) was from Atto Instruments; fura-2AM, fura-2 pentapotassium salt, fluorescein, and rhodamine were from Molecular Probes; thapsigargin was from Research Biochemicals (Natick, MA); Ro2O-1724 was from Biomol (Plymouth Meeting, PA). Cell culture products and all other drugs were from Sigma.
RESULTS AND DISCUSSION
Simultaneous cAMP/Ca2+ Imaging Feasibility Studies.
The feasibility of cAMP/Ca2+ simultaneous fluorescence imaging in single cells was tested in situ by comparing the response of FICRhR and fura-2 to agents known to increase
[cAMP]j and [Ca2+]i, respectively, in C6-2B cells labeled with either FICRhR or fura-2 versus cells colabeled with both dyes. As shown in Fig. 1 A and B , exposure of the cells to the synthetic catecholamine, isoproterenol (ISO), resulted in an increase in the FICRhR 520/580 nm emission ratio (reflecting increased cAMP synthesis) whose extent was virtually identical in cells labeled with FICRhR only (Fig. 1A ) and in cells colabeled with FICRhR and fura-2 (Fig. 1B) . Likewise, application of the Ca2+ ionophore, ionomycin (IONO), evoked an increase in fura-2 334/380 nm excitation ratio, reflecting a rise in [Ca2+]j, which was comparable between cells labeled with fura-2 only (Fig. 1C ) and cells colabeled with both fura-2 and FICRhR ( Fig. 1D ). Therefore, this first set of experiments demonstrates that the detection of the fluorescent signal generated by either FICRhR or fura-2 is not appreciably affected by the simultaneous presence of both dyes in the same cell.
We then investigated whether an increase in fura-2/FlCRhR excitation/emission ratio upon activation of the Ca2+/cAMP pathway would affect the response of either dye to a concomitant or subsequent challenge. Because Ca2+ is known to Proc. Natl. Acad. Sci. USA 93 (1996) Proc. Natl. Acad. Sci. USA 93 (1996) 4579 inhibit cAMP synthesis in C6-2B cells (8) (9) (10) (11) sequent cAMP accumulation by FO (Fig. 2B) nor did TG impair the FlCRhR response evoked by FO (Fig. 2C) provides in vivo evidence for a dynamic regulation by Ca2+ of agonist-induced cAMP production in specific cell types, and (iii) demonstrates the utility of this dual-dye ratio imaging technique for the study of the spatial and temporal interactions between Ca2+ and cAMP, and potentially other intracellular regulatory messengers, at the single cell and subcellular level.
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